Literature DB >> 2187415

Cytokines and eicosanoids in rheumatic diseases.

S J Hopkins1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187415      PMCID: PMC1004033          DOI: 10.1136/ard.49.4.207

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  25 in total

Review 1.  G-protein subunits. Who carries what message?

Authors:  H R Bourne
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

2.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells.

Authors:  S Endres; R Ghorbani; V E Kelley; K Georgilis; G Lonnemann; J W van der Meer; J G Cannon; T S Rogers; M S Klempner; P C Weber
Journal:  N Engl J Med       Date:  1989-02-02       Impact factor: 91.245

3.  Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha.

Authors:  B D Gitter; J M Labus; S L Lees; M E Scheetz
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

4.  Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -independent mechanisms.

Authors:  J A Elias
Journal:  Am Rev Respir Dis       Date:  1988-09

5.  Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6.

Authors:  Y H Zhang; J X Lin; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

6.  Interleukin-1 stimulation of phospholipase activity in rat synovial fibroblasts. Possible regulation by cyclooxygenase products.

Authors:  R W Godfrey; W J Johnson; S T Hoffstein
Journal:  Arthritis Rheum       Date:  1988-11

7.  Cyclic AMP--an intracellular second messenger for interleukin 1.

Authors:  F Shirakawa; U Yamashita; M Chedid; S B Mizel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Synergism between parathyroid hormone and interleukin 1 in stimulating bone resorption in organ culture.

Authors:  F E Dewhirst; J M Ago; W J Peros; P Stashenko
Journal:  J Bone Miner Res       Date:  1987-04       Impact factor: 6.741

9.  Synergy of interleukin 1 (IL-1) with arachidonic acid and A23187 in stimulating PGE synthesis in human fibroblasts: IL-1 stimulates fibroblast cyclooxygenase.

Authors:  J H Korn; E Downie; G J Roth; S Y Ho
Journal:  Clin Immunol Immunopathol       Date:  1989-02

10.  Tumour necrosis factors modulate the affinity state of the leukotriene B4 receptor on human neutrophils.

Authors:  J Brom; J Knöller; M Köller; W König
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

View more
  10 in total

Review 1.  The cytokines are coming.

Authors:  K P Windebank
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

Review 2.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

3.  Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.

Authors:  A S Williams; S G Jones; R M Goodfellow; N Amos; B D Williams
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  Inhibition by prostaglandin E1 and E2 of 1,25-dihydroxyvitamin D3 synthesis by synovial fluid macrophages from arthritic joints.

Authors:  M E Hayes; A Rai; R G Cooper; D Bayley; A J Freemont; E B Mawer
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

5.  Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids.

Authors:  G T Espersen; N Grunnet; H H Lervang; G L Nielsen; B S Thomsen; K L Faarvang; J Dyerberg; E Ernst
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

6.  Black tea (Camellia sinensis) decoction shows immunomodulatory properties on an experimental animal model and in human peripheral mononuclear cells.

Authors:  Chandan Chattopadhyay; Nandini Chakrabarti; Mitali Chatterjee; Sonali Mukherjee; Kajari Sarkar; A Roy Chaudhuri
Journal:  Pharmacognosy Res       Date:  2012-01

7.  Interleukin-6 in peripheral blood and inflammatory sites in Behçet's disease.

Authors:  K Hamzaoui; A Hamzaoui; A Kahan; M Hamza; A Chabbou; K Ayed
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

8.  Evaluation of anti-inflammatory activity of methanolic extract of leaves of Bougainvillea spectabilis in experimental animal models.

Authors:  Gautam Mandal; Chandan Chatterjee; Mitali Chatterjee
Journal:  Pharmacognosy Res       Date:  2015 Jan-Mar

9.  Preeclampsia Status Controls Interleukin-6 and Soluble IL-6 Receptor Release from Neutrophils and Endothelial Cells: Relevance to Increased Inflammatory Responses.

Authors:  Yuping Wang; Yang Gu; J Steven Alexander; David F Lewis
Journal:  Pathophysiology       Date:  2021-04-08

10.  Lack of involvement of lipocortin 1 in dexamethasone suppression of IL-1 release.

Authors:  E F Morand; D Rickard; N J Goulding
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.